Earnings Call for the Unaudited Financial Results for the quarter and half year ended September 30, 2026

Date: October 30, 2026 BSE Limited, National Stock Exchange of India Limited 20th Floor, P.J. Towers, Dalal Street, Exchange Plaza, C-1, Block G, Mumbai - 400001. Bandra Kurla Complex, BSE Scrip Code: 544449 Bandra (E), Mumbai – 400 051 NSE Scrip Symbol: ANTHEM Subject: Intimation of Schedule of Earnings Conference Call under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Dear Sir/Ma’am Pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that an Earnings Conference Call to discuss the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2026, is scheduled on Wednesday, November 04, 2026 at 12:30 PM IST. The details pertaining to the said call are enclosed herewith and the same will also be available on the Company’s website at https://anthembio.com/ We request you to kindly take the same on record. Thanking you, Yours truly, For Anthem Biosciences Limited (Formerly known as Anthem Biosciences Private Limited) Divya Prasad Company Secretary & Compliance Officer Membership No: A41438 The Management of Anthem Biosciences Limited Invites you to the Q2 & H1 FY27 Earnings Conference Call To discuss the performance for the quarter and half year ended September 30, 2026 Day/Date: Wednesday, 4th November, 2026 Time: 12:30pm IST OPTION 1 | Diamond Pass Pre-registration link: CLICK HERE OPTION 2 | Dial-in through Operator Assistance Participants are requested to dial-in 5 minutes in advance For more information: Investor Relations Team Anthem Biosciences: +91 80 6672 4172|Email: investors.abl@anthembio.com